Is Wellorithm Legit? What Our Registry Shows (2026)

Is Wellorithm a real, safe GLP-1 telehealth company? Verified pricing history, states served, and a claimed Trustpilot profile with a single review to date, sourced from RangeYourself’s dated registry. Wellorithm does not publicly list pricing; confirm refund terms and price at intake.

By RangeYourselfLast verified July 25, 2026

Yes, Wellorithm is a real, operating GLP-1 telehealth company. RangeYourself has independently verified its pricing directly against its own site (one dated price record from July 1, 2026, last verified July 25, 2026), and its refund/cancellation terms and states served are published on its own site. The evidence for that verdict is the dated verification below, not a claim we’re asking you to take on faith.

When we verified Wellorithm

RangeYourself’s price record for Wellorithm is a single dated entry from July 1, 2026, sourced directly from Wellorithm’s own site, and the price was last verified on July 25, 2026. That is a single verification, not an ongoing trail, so treat it as a snapshot and confirm current pricing with Wellorithm.

Pricing verification history

July 1, 2026: no assertable public price

Refund and cancellation policy

Wellorithm’s own stated policy: Not publicly listed, confirm refund terms during intake

Price and terms on file

Not publicly listed, confirm at intake.

States served

Wellorithm ships to all US states except Louisiana, per its own site (verified July 25, 2026).

What the records show

Wellorithm's Trustpilot presence is a single review, far too small a sample to draw a conclusion from, and we found no BBB listing to supplement it.

Trustpilot: 3.7★ (1 review), small sample via Trustpilot, checked 2026-07-24

Single review, sample far too small to be representative. Trustpilot itself notes "no recent history of asking for reviews."

Independently observed third-party data, not our own editorial score. Full methodology: GLP-1 Provider Reliability Report.

Verified programs with a published all-in monthly price

Wellorithm’s price on file has not passed our current verification cycle, so it is not compared here. The programs below carry a verified all-in monthly price, checked on each provider’s own pricing page and ranked lowest first as of November 10, 2026.

1.Embody
$69/mo (limited-time promo), verified October 21, 2026
See pricing →
2.Yucca Health
$69/mo (12-month plan rate), verified November 7, 2026
See pricing →
3.HealthRX
$97/mo (12-month Subscribe & Save plan rate), verified November 10, 2026
See pricing →
4.Sprout Health
$99/mo (12-month plan rate), verified November 3, 2026
See pricing →
5.Strut Health
$99/mo (sublingual/oral starting price), verified September 28, 2026
See pricing →

Prices are each provider’s own published all-in monthly figure at the plan term shown, verified on the date listed. RangeYourself may earn a commission from some programs; that can only break an exact tie between verified equals and never changes the price order.

See Wellorithm pricing → Read the full Wellorithm review →

Frequently asked questions

Is Wellorithm a real company?

Yes. RangeYourself has independently verified Wellorithm's pricing directly against its own site (wellorithm.com) with a single dated price record on file from July 1, 2026, last verified July 25, 2026, and its refund policy and states served are published on its own site.

Is Wellorithm FDA-approved?

Wellorithm offers both compounded GLP-1 medication (not individually FDA-approved) and brand-name GLP-1 medication (Wegovy, Ozempic, Mounjaro, and Zepbound), which are FDA-approved products (Wegovy and Zepbound for chronic weight management, Ozempic and Mounjaro for type 2 diabetes), depending on eligibility.

Does Wellorithm offer refunds or a guarantee?

Wellorithm's own stated policy: Not publicly listed, confirm refund terms during intake This is the program's own policy, not a promise from RangeYourself, confirm current terms directly with Wellorithm before enrolling.

What do independent reviews show for Wellorithm?

3.7★ on Trustpilot from 1 review, a small sample (checked 2026-07-24). This is third-party data, not RangeYourself's own editorial score.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. This legitimacy check reflects registry data verified through July 25, 2026 and may change.